12-month weight-loss trajectories and predictors of response to tirzepatide under individualized dosing: A multicenter real-world study. (PubMed, Obes Pillars) - Oct 25, 2026 - "This was a multicenter, retrospective, observational real-world study including 249 adults with overweight or obesity treated with tirzepatide across 13 obesity practices in Greece...Six-month weight-loss response was associated with the likelihood of achieving ≥20% weight loss at 12 months. These findings do not establish long-term weight maintenance beyond the observation period."
Journal • Real-world evidence • Genetic Disorders • Obesity
|
|
Alexander Kokkinos; Andreas Rizoulis; Dimitra Zianni; Dimitrios Askitis; Dimos Florakis; Evangelos Fousteris; Evdoxia Gitsi; Georgia Argyrakopoulou; Ilias Perogamvros; Ioannis Androulakis; Nikolaos Angelopoulos; Ploutarchos Tzoulis; Rodis Paparodis; Sarantis Livadas; Vaia Lambadiari; Valentina Petkova; Zadalla Mouslech
|